We are live on ! Find out more
FBCG

Fidelity Blue Chip Growth ETF

Delisted

FBCG was delisted on the 29th of July, 2026.

197 hedge funds and large institutions have $2.72B invested in Fidelity Blue Chip Growth ETF in 2025 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 92 increasing their positions, 40 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 40

86% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 22

9% more funds holding

Funds holding: 181197 (+16)

7% more funds holding in top 10

Funds holding in top 10: 1415 (+1)

5% less capital invested

Capital invested by funds: $2.86B → $2.72B (-$146M)

22.25% less ownership

Funds ownership: 99.14%76.89% (-22%)

Holders
197
Holders Change
+16
Holders Change %
+8.84%
% of All Funds
2.64%
Holding in Top 10
15
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.14%
% of All Funds
0.2%
New
41
Increased
92
Reduced
40
Closed
22
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
LPL Financial
101
LPL Financial
California
$1.02M +$441K +9,741 +62%
CAPTRUST Financial Advisors
102
CAPTRUST Financial Advisors
North Carolina
$1.01M +$355K +7,850 +45%
Qube Research & Technologies (QRT)
103
Qube Research & Technologies (QRT)
United Kingdom
$923K -$71.2K -1,574 -6%
NA
104
NewEdge Advisors
Louisiana
$921K -$101K -2,240 -9%
CIR
105
Clear Investment Research
Georgia
$870K +$87.5K +1,935 +10%
SMAM
106
Sugar Maple Asset Management
Wisconsin
$837K +$948K +20,948 New
SS
107
Sunbelt Securities
Texas
$781K +$40.9K +903 +5%
HPC
108
Hobart Private Capital
North Carolina
$742K +$118K +2,605 +16%
PW
109
PUREfi Wealth
Massachusetts
$722K +$251K +5,543 +44%
MF
110
Meridian Financial
Massachusetts
$721K -$31.8K -702 -4%
TCM
111
Traynor Capital Management
Pennsylvania
$717K +$214K +4,724 +36%
IAG
112
Investment Advisory Group
Massachusetts
$716K -$31.3K -692 -4%
YWS
113
Yarger Wealth Strategies
Ohio
$688K
TCM
114
Tandem Capital Management
New Jersey
$654K -$1.81K -40 -0.2%
SPA
115
Sentinel Pension Advisors
Massachusetts
$642K +$33.8K +748 +5%
MIA
116
Milestone Investment Advisors
Wisconsin
$636K +$720K +15,924 New
AWM
117
Avaii Wealth Management
Wisconsin
$590K +$6.42K +142 +1%
Bank of New York Mellon
118
Bank of New York Mellon
New York
$589K +$426K +9,414 +177%
D.E. Shaw & Co
119
D.E. Shaw & Co
New York
$564K
AFG
120
Atomi Financial Group
New York
$494K +$5.57K +123 +1%
IAIM
121
International Assets Investment Management
Florida
$491K +$11.5K +255 +2%
FTS
122
Fifth Third Securities
Ohio
$465K -$73.1K -1,616 -12%
1CP
123
17 Capital Partners
Arizona
$461K +$23.8K +526 +5%
EFG
124
Elm3 Financial Group
Georgia
$440K +$258K +5,710 +108%
LFA
125
LGT Financial Advisors
Texas
$440K +$498K +11,000 New

FBCG Hedge Fund Activity: Q1 2025 in Review

197 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Fidelity Blue Chip Growth ETF (FBCG) for Q1 2025, worth a combined $2.72B — down 5.1% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new FBCG positions and 22 closed out — a net gain of 19 holders — while 92 added to existing stakes and 40 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $61.1M. The largest seller was Thrivent Financial for Lutherans, exiting entirely with an estimated $91M sold.

  • 197 institutional investors held Fidelity Blue Chip Growth ETF (FBCG) as of Q1 2025, up from 181 in Q4 2024.
  • Funds reported $2.72B of Fidelity Blue Chip Growth ETF stock for Q1 2025, down 5.1% quarter-over-quarter.
  • 41 funds opened new Fidelity Blue Chip Growth ETF positions in Q1 2025 and 22 closed out, a net change of +19 holders.
  • The largest Fidelity Blue Chip Growth ETF buyer in Q1 2025 was JP Morgan Chase, an estimated $61.1M added.
  • The largest Fidelity Blue Chip Growth ETF seller in Q1 2025 was Thrivent Financial for Lutherans, an estimated $91M sold.

Based on aggregated 13F filings for Q1 2025.